Phylogenetic analysis demonstrated that the new isolate, A/Changsha/1/2014 (H5N6), is a novel triple reassortant H5N6 virus.
A/Changsha/1/2014 (H5N6) has not gained genetic mutations necessary for efficient human infection.
Sequence data of A/Changsha/1/2014 (H5N6) indicate neuraminidase sensitivity and adamantane resistance.
Detection of asymptomatic carriers should be part of future contact-tracing plans.
Neuraminidase inhibitors may serve as the frontline intervention for preventing and controlling potential outbreaks.